GreenLight Clinical, a physician-led Clinical Research Organization and Laboratory has announced that Dr. Robert Lin will take over the Chief Executive Officer role.
In a statement made by current CEO, Dr. Grace Pei, she said “We are very pleased to announce that Dr. Robert Lin is taking over as our new CEO. I am confident that his extensive experience in the healthcare industry will help take GreenLight Clinical to the next level and beyond.”
Dr. Lin brings with him a wealth of knowledge and experience in the clinical research space, with over 20 years of clinical and managerial experience. As a healthcare professional who is passionate about advancing medical facilities, treatments, and patient-centric care, Dr Lin has extensive experience in managing private, public, and international hospitals and other facilities. His expertise spans strategic planning, improving operational efficiency, team building, and project management.
In his new role at GreenLight Clinical, Dr. Lin will lead the organization’s strategic direction while focusing on operational excellence, customer service, and innovation across its full suite of services including both the clinical research solutions and central laboratory services for biotech companies worldwide.
“I am excited to join GreenLight Clinical at this pivotal time,” said Dr. Lin in an official statement released today. “I look forward to working closely with our team to further strengthen our capabilities and deliver value-added services that meet our customers’ needs.”
GreenLight Clinical’s Chairman of the Board, Dr Andrew Chang expressed confidence in Dr. Lin’s ability to lead the company into its next phase of growth saying “We are thrilled to welcome Robert as our new CEO; his deep expertise in managing global teams will be invaluable as we continue our mission to make clinical research processes more efficient through innovative solutions.”
About GreenLight Clinical
GreenLight Clinical is a physician-led, boutique full-service clinical CRO with its own central clinical, bioanalytical, and histopathology laboratory in Sydney, Australia. GreenLight Clinical has offices in Australia and USA, with a global footprint. We were founded in 2015 as a CRO by Dr. Andrew Chang, expanding to laboratory services in 2020. Combining medical expertise and deep industry knowledge, GreenLight Clinical develops bespoke solutions to accelerate innovative treatment development for patients with unmet needs.
For more information, please contact:
Michelle Granzow
Marketing Manager
GreenLight Clinical
E: michelle.granzow@greenlightclinical.com